The global [FURL=https://www.industryarc.com/Report/18537/life-sciences-artificial-intelligence-ai-market.html?utm_source=briefingwire&utm_medium=Pressrelease&utm_campaign=Paidpressrelease]Life Sciences Artificial Intelligence Market[/FURL] size is estimated to surpass $324.2 million mark by 2026 growing at an estimated CAGR of more than 13.1% during the forecast period 2021 to 2026. Life Sciences Artificial Intelligence provides potential to improve the health care system especially personalized medicine and drug development. With the implementation of AI it becomes possible for the healthcare organization to drive innovation and achieve various outcomes including hyper-personalized experiences, new sources of growth, and new levels of efficiency. In 2019, the adoption of technologies such as AI has reshaped the life science industry. The innovation in the life science industry will also lead to provide growing potential for healthcare organizations. Artificial Intelligence is proved to be an advanced tool which is reshaping the Life Sciences industry. The rising application in initiating drug discovery and development is fuelling the need for Life Sciences AI industry.Key Takeaways
What can be automated, will be automated - initially, there were several steps of drug development and clinical research which are very expensive to perform, which took time and were labor demanding. If pharmaceutical companies starts different stages along with automation automatically it will save money, time and rises success rates.
Building Unified Models will support the estimation of future behavior of compounds and their performance in confused clinical trials. Mainly, there are 2 stages which are accessible: estimating toxicity and estimating efficacy of combined therapies.
Request for Sample of the Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=18537[/FURL]
Life Sciences Artificial Intelligence (AI) Market - By Geography
North America region dominated the global life sciences AI market as of 2020. It is due to the presence of significant players namely TwoXAR Pharmaceuticals, NuMedii, Numerate, Inc. and IBM Corporation. These players are focusing on their offerings of advanced platform for the life science industry. The advanced AI platform establishes enhanced drug development programs thus reshaping the life science industry. The pharmaceutical companies are also looking for partnerships, collaboration and joint venture with the AI startups for enhancing the deployment of AI –based technologies in the life sciences market.
Life Sciences Artificial Intelligence (AI) Market Drivers
Acceleration of Advanced Diagnostics and Drug Development
Emerging Machine Learning, and Clinical Site Selection along with the Acceleration of Patient Identification
Life Sciences Artificial Intelligence (AI) Market top 10 companies are TwoXAR, Numerate, NuMedii, IBM, and Envisagenics and others.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.